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ABSTRACT  TWO monoctonal  antibodies  (mabs) previously  prepared  against Torpedo  acetyl- 
choline  receptor are shown to recognize a synthetic nonadecapeptide  corresponding to lys360- 
glu377 of the gamma subunit.  The reaction was demonstrated  by solid-phase enzyme-linked 
immunoabsorbent  assays, by inhibition of binding  of the mabs to receptor,  and by immuno- 
precipitation  of  the  peptide  conjugated  to  bovine  serum albumin.  Immunogold  electron 
microscopy  on isolated postsynaptic membranes from  Torpedo showed that both  mabs bind 
to intracellular epitopes on the receptor. These results establish that amino acid residues 360- 
377 of the receptor  gamma-subunit, and probably the analogous region of the delta-subunit, 
reside on  the  cytoplasmic  side of the  membrane.  Since the  primary  structures of all  four 
subunits suggest a common transmembrane arrangement, the corresponding  domains of the 
alpha- and beta-subunits are probably also cytoplasmic. 
The recent identification of the amino acid sequences of all 
four  subunits  of the  acetylcholine  receptor  (AChR) 1 from 
Torpedo electric organ (5, 7, 24, 29, 36) has led to models for 
the transmembrane folding pattern of the subunits and for 
the structure of the receptor's ion channel (for a review, see 
reference 27).  The results of these studies are likely to be of 
wide impact, because the receptors from Torpedo and mam- 
malian  muscle  share  extensive  homology (6,  21,  25)  and 
because they  may provide a  theoretical  framework for the 
structure and  function of other neurotransmitter receptors. 
Thus, prompt direct tests of these models are of major im- 
portance. 
The polypeptide chain of each receptor subunit contains a 
large hydrophilic domain at the N-terminus followed by three 
closely spaced  hydrophobic  regions,  a  second  large hydro- 
philic domain, and a fourth hydrophobic domain (5, 7, 26). 
The recent identification of cysteine 192 as part of the alpha- 
Abbreviations  used  in this paper:  AChR, nicotinic acetylcholine 
receptor; ELISA, enzyme-linked immunoabsorbent assay; KLH, key- 
hole limpet hemocyanin; mab, monoclonal antibody. 
chain that contributes to the acetylcholine-binding site (41) 
and evidence from cell-free synthesis of receptor subunits (1) 
establish that the large N-terminal domain is extracellular. In 
folding models based on hydrophobicity analyses alone, the 
hydrophobic  domains  form  the  only  transmembrane  ele- 
ments, probably as helices.  Hence, these models predict that 
the second hydrophilic domain lies on the cytoplasmic side 
of the membrane and that the C-terminus is extracellular (5, 
7, 26).  Searches of the sequences for repeating arrangements 
of nonpolar  and  polar  residues,  however,  have  produced 
evidence for an additional, amphipathic helix just preceeding 
the fourth hydrophobic helix (9,  17). Thus,  in this class of 
model, the large cytoplasmic domain is smaller and the C- 
terminus is cytoplasmic. In a third model, the second hydro- 
philic domain is divided roughly into two halves joined by a 
transmembrane element (19). 
The most direct initial tests of the proposed folding patterns 
require localization  of identified  regions of the amino acid 
sequences relative to the membrane bilayer. Antibodies raised 
against synthetic peptides that correspond to selected receptor 
polypeptide sequences or existing antibodies whose epitopes 
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experiments. Thus, peptides corresponding to the C-terminal 
sequences have been used to screen a monoclonal library and 
as immunogens for the production of antibodies (42, 43). The 
resulting  antibodies  recognize  cytoplasmic epitopes on  the 
membrane-bound receptor (42,  43), supporting the existence 
of an amphipathic transmembrane region. In this paper, we 
show that two monoclonal antibodies (mabs) raised against 
denatured AChR recognize a synthetic peptide corresponding 
to amino acid residues 360-377 of the gamma subunit. This 
region  lies  within  the  second hydrophilic domain,  and has 
been predicted to be exposed to the cytoplasm (5,  7, 9,  17, 
26) or embedded in the membrane (19). Using ultrastructural 
immunocytochemistry, we show that these mabs react with 
exposed cytoplasmic epitopes, and that these epitopes are not 
involved  in  binding  of the  receptor-associated  Mr  43,000 
protein. 
MATERIALS  AND  METHODS 
Antibodies:  The production  and characterization  of the mabs to Tor- 
pedo caliJbrnica AChR  and the  purification  of IgG from ascites fluids have 
been  described  (13). Rabbit  antitoxin  antibodies  (IgG) were raised  against 
hemocyanin-coupled  a-neurotoxin  I11 from Naja naja siamensis venom (18), 
isolated by ammonium sulfate precipitation and ion exchange chromatography 
(15), and afffinity-purified by standard procedures. 
Synthetic Peptides:  The nonadecapeptide that corresponds to amino 
acid sequence 360-377 of the AChR gamma subunit (plus a cysteine on the 
carboxyl terminus)  was synthesized by Sequemat Inc. (Watertown, MA). The 
peptide was judged to be homogeneous by high performance liquid chromatog- 
raphy performed by the supplier and by fast protein liquid chromatography ion 
exchange chromatography  using a  Pharmacia  Mono Q  column (Pharmacia 
Fine Chemicals, Piscataway, N  J). The sequence was verified by the supplier. 
Disulfide-linked dimer of the  peptide  was formed  by incubation  of peptide 
dissolved at 1 mM in  10 mM sodium phosphate, pH 8.0, 0.02% NaN3 for 40 
h at room temperature.  Less than 0.2% of the sulfhydryl groups remained  in 
the reduced form after this treatment.  The hexadecapeptide corresponding to 
residues  485-499  of the  delta  chain  and  its bovine  serum albumin (BSA) 
conjugate were kindly provided by Dr. Robert Stroud's laboratory (University 
of  California at San Francisco). This peptide has the sequence Ac-Pro-Phe-Glu- 
Gly-Asp-Pro-Phe-Asp-Tyr-Ser-Ser-Asp-His-Pro-Arg-Gly-OH. 
Preparation of the Peptide Conjugate:  A modification  of the 
procedures  described  by  Gentry et  al.  (16) for attachment  of peptides  via 
sulfhydryl groups to carrier proteins was used. All procedures were performed 
at 25°C. BSA (4 mg dissolved in 250 ~1 of 10 mM sodium phosphate, pH 7.4) 
was alkylated with 250 nmol of N-ethylmaleimide for 10 min and then ten  10- 
;zl  aliquots  of maleimidobenzoyl-N-hydroxysuccinimide  ester  (20  mg/ml in 
dimethylformamide)  was added. After 30 min, the sample was passed through 
a 0.8 x  18 cm BioGel P60 column equilibrated with 50 mM sodium phosphate 
buffer, pH 6.0, to remove excess alkylating agent and maleimidobenzoyl-N- 
hydroxysuccinimide  ester. Fractions  corresponding  to the  void volume were 
pooled and adjusted to pH 7.4 with 1 N NaOH. This sample was then divided 
into  two  parts  and  one was  mixed  with  1.5  mg gamma-peptide  360-377 
(dissolved in 200 ul  10 mM sodium  phosphate,  pH 7.4). The other part was 
mixed with buffer and served as control  BSA. After incubation  for 4 h, the 
conjugate  was separated from the  free peptide on a Sephadex G-50  column 
equilibrated  in  l0  mM  sodium  phosphate,  0.15 M  NaC1, pH  7.4  (PBS). 
Comparison  of the  amino acid compositions  of peptide-BSA conjugate  and 
control BSA showed that ~7 mol of peptide were conjugated per mol of BSA. 
The keyhole limpet hemocyanin  (KLH) conjugate was prepared  in a similar 
manner. 
Radioiodination of Peptide-BSA Conjugate:  Peptide-BSA con- 
jugate (125 t~g) or control  BSA (125 #g) was incubated  with 0.1  nmol Na~25I 
(200/aCi) and 225 nmol chloramine T in 65 ul of 0.1  M NaPO4, pH 7.4, for 1 
min on ice. The reaction was stopped by the addition of 5 vmol of  dithiothreitol 
and the iodinated protein was separated from sodium iodide by chromatography 
on a BioGel P60 column equilibrated with PBS. Specific radioactivities of 26 
#Ci/nmol for the conjugate and 20 vCi/nmol for control  BSA were obtained. 
Enzyme-linked tmmunoadsorption  Assay:  Microtiter wells of 
a Falcon flexible assay plate (3912) were incubated with peptide-BSA conjugate 
or control  BSA (300 ng in 50 ul of PBS, 0.02% azide) for 2 h. The solutions 
were removed, the wells were incubated with PBS/NaN3 containing  4% BSA 
for 30 min, and the plates were then washed with PBS/NaNa containing 0.05% 
Tween. All subsequent  washes were done with the same solution.  The wells 
were then incubated  with 50/,1  mab IgG (diluted in PBS/NaN3/Tween  con- 
taining  1%  BSA) for 2  h, washed, and then incubated  with antimouse  im- 
munoglobulin  conjugated  to  ~-galactosidase (BRL  Scientific, Gaithersburg, 
MD) (1:100) for 3 h. The wells were washed again and incubated  with para- 
nitrophenyI-B-D-galactoside ( I mg/ml) dissolved in 50 mM sodium phosphate 
buffer, pH 7.2, 1.5 mM MgCI2, and 100 mM 2-mercaptoethanol. The reaction 
was quenched  with 0.5 M sodium carbonate  and absorbance was read at 405 
nm. 
For the  inhibition  of binding experiments,  mabs were incubated  with the 
inhibitor  (peptides,  peptide-BSA conjugate,  control  BSA) for  1 h  and  then 
transferred to wells coated with 500 ng purified Torpedo nobiliana AChR (12). 
After incubation  for times determined  in separate experiments to give 50-70% 
maximal binding of mabs, the plates were processed as described above. The 
following IgG concentrations  were used: 10 nM for 88B and 147A; 20 nM for 
264E, 139A, 240A, 245A, 262C, and 280B; 40 nM for 274D. 
Immunoprecipitation of Radioiodinated Peptide-BSA  Con- 
jugate:  Mab IgG (10 td) was incubated with l0 ~1 of 125I-peptide conjugate 
or control  BSA (250 fmol) for 60  min.  Immunoprecipitation  was then per- 
formed with fixed Staphylococcus aureus as previously described (13) with the 
following modification.  Complexes  of anti-mouse  IgG and  S.  aureus were 
preformed by incubation  of 150 ul of rabbit anti-mouse  IgG serum with  1 ml 
of  IgGsorb ( 10%; The Enzyme Center, Boston, MA) for 30 min at 37"C, washed 
to remove unbound antibody, and resuspended in the original volume. 30 ~1 
was added to each reaction mixture to precipitate the mabs. 
Preparation of Membrane  Fragments:  Partially  purified AChR- 
rich membrane fragments were prepared  from frozen  T.  californica electric 
tissue by two procedures. (a) Extracted membranes: Membranes were prepared 
according to Sobel et al. (35), except that 5 mM EDTA was added to the first 
supematant to retard  proteolysis and  the  final, linear  sucrose gradient  was 
omitted.  The membranes in the receptor-rich  fraction  of the  discontinuous 
gradient  were pelleted, resuspended  in  water, adjusted  to pH  11  with  I  M 
NaOH,  sonicated  for 0.5-1  min at  room temperature  in  a  small bath-type 
sonicator (Sonicor Instrument Corp., Copiague, NY), pelleted, resuspended in 
water to their initial volume, and stored frozen in 50-ul aliquots. (b) Nonex- 
tracted membranes: Tissue was homogenized in 25 % sucrose-2 mM ZnC12 and 
fractionation  by differential and sucrose gradient centrifugation  (unpublished 
results; 34) to obtain a crude fraction of membranes in the form of open sheets 
and tubes. These membranes were prepared shortly before use. 
Colloidal Gold Particles:  Colloidal  gold was prepared using sodium 
citrate  (15-nm  gold particles;  10,  31)  or sodium  citrate/tannic  acid  (5-nm 
particles; 22) as the reducing agent. Each size was complexed with S. aureus 
protein A (Pharmacia Fine Chemicals) by standard methods (e.g., see reference 
31) as modified by Wray and Sealock (39). The large and small gold particles 
were used for labeling at absorbances of 2.0 at  520 nm and  1.0 at 505  nm, 
respectively. 
Labeling Procedure:  Membrane fragments were labeled with 0.1 ~M 
mab 264E lgG or 0.2 vM  mab 274D  IgG followed by rabbit antimouse  IgG 
serum diluted  1:50 and protein A-5 nm colloidal gold. They were then labeled 
with  1 t*M a-toxin,  1 ~M antitoxin  lgG, and protein A-15 nm colloidal gold. 
These procedures were performed  using polylysine-coated microculture  wells 
as described by Wray and Sealock (39) with some modifications. After appli- 
cation to well bottoms by centrifugation, the membranes were fixed with 0.2% 
glutaraldehyde (electron microscopy grade, Polysciences, Inc., Warrington, PA) 
for 30 min, then treated with NaBH4 (1  mg/ml, 30 min) to reduce aldehydes 
and SchilTs bases (38) and possibly to restore antigenicity (8). This fixation/ 
reduction step was repeated between the incubations  with antireceptor  mabs 
and rabbit antimouse lgG. A third fixation ( 1% glutaraldehyde) and reduction 
was given after application of protein A-5 nm colloidal gold. Preliminary tests 
established that  these fixations did  not diminish  the effectiveness of the im- 
munochemical  steps. After application of protein  A-15 nm colloidal gold, the 
membranes were fixed with 1.6% glutaraldehyde-tannic acid in PBS at pH 7.3, 
and prepared for electron microscopy as described (39). 
In competition experiments, mabs were diluted to their final concentration 
in solutions  of peptide dimer at various concentrations.  The solutions  were 
incubated  for 30  min  at  room temperature  and centrifuged  for 20  min at 
20,000 g. 
Receptor-rich membrane fragments were identified by the presence of label- 
ing on the c~-neurotoxin. Within aggregations of membranes,  fragments were 
often labeled by antireceptor mabs but not by the a-toxin,  certainly because of 
hindrance of access of reagents to the outer surfaces of the fragments (see Fig. 
6 A). These fragments were excluded from all analyses. Three experiments gave 
identical qualitative results and one was selected for quantitative analysis. Every 
receptor-rich  fragment  or portion  thereof  for which  there  was no  obvious 
impediment to labeling (such as adhesion to an adjacent fragment) was identi- 
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RESULTS 
Selection of the Synthetic Peptide 
In  previous work,  we  generated  a  panel  of monoclonal 
antibodies against the AChR from Torpedo  (13). Four of  these 
mabs (88B,  147A, 264E, and 274D) were found to react with 
both the gamma- and delta-subunits of the receptor on im- 
munoblots. (Mab 264E was originally  reported to recognize 
only the delta-subunit. Recently, however, we have found that 
it also recognizes the gamma-subunit under certain conditions 
of immunoblotting  [unpublished  results].)  Binding  studies 
with isolated membranes suggested that these mabs recognize 
cytoplasmic determinants. Therefore, we sought to identify a 
proposed  cytoplasmic  sequence  that  was  hydrophilic,  was 
likely  to be  antigenic,  and  had  considerable homology be- 
tween  the  delta-  and  gamma-subunits  while  sharing  little 
homology with the other subunits.  This led to the selection of 
gamma-peptide 360-377,  the sequence of which is shown in 
Fig.  l, as a candidate for the binding site for one or more of 
the anti-AChR mabs.  (Numerical assignments of amino acid 
positions begin with the first residue  of each mature subunit 
and continue without gaps.) The peptide shares 67% homol- 
ogy (12 of 18 residues identical) with the corresponding region 
(residues  368-385)  of the delta-subunit (Fig. 1). Comparison 
of all tripeptide  sequences present  in  the  synthetic peptide 
with the entire sequences  of each of the subunits shows the 
following identities:  Ala-Glu-Glu, alpha 395-397 and gamma 
162-164; Leu-Lys-Lys, beta 424-426; Leu-Met-Phe, beta 284- 
286 and delta 292-294;  Ser-Glu-Leu, gamma 82-84.  No se- 
quence identities  longer than tripeptides  were  found.  Since 
antigenic determinants are comprised of a sequence of six or 
seven residues (2), antibodies directed against this peptide are 
highly unlikely to recognize epitopes located outside the re- 
gion  360-377  of the  gamma-subunit  and  the  homologous 
region of the delta-chain. 
Mabs 264E and 274D Recognize 
Gamma-Peptide 360-377 
The  set  of  AChR  mabs  was  screened  for  reactivity 
with  gamma-peptide 360-377  conjugated to BSA and KLH 
using a  solid-phase  enzyme-linked immunoabsorbent assay 
(ELISA).  Mabs  274D  and  264E  were  found  to  bind  the 
conjugates; they did  not bind  BSA or KLH that had been 
treated with cross-linker  in the absence of the peptide (Fig. 
2). Nine other mabs, including ones that recognize the AChR 
delta-subunit (240A,  245A,  262C,  280B),  the gamma- and 
the delta-subunits (88B, 147A), and the alpha-subunit (139A) 
and  two  control  mabs that  do  not  recognize  the  receptor 
(MPC-1 l,  MOPC-21)  were  unreactive with  either  peptide- 
BSA or peptide-KLH. None of the anti-AChR mabs reacted 
PEPTIDE  LFs-A  la-G  lug3  lu-T  yr  -I  le-Leu-Lys-Lyslpro-Ar  g~er  -G  lu-Leu-Met -Phe-G  lu~lu  ~ ys 
GAMMA SUBUNIT  Lys-Ala-Glu-Glu-Tyr-lle-Leu-Lys-Lys-Pro-Arg-Ser-Glu-Leu-Met-Phe-Glu-Glu 
360  377 
D~TA SUBUNIT  Lys-Ala-Gln~lu-Tyr-Phe-Asn-Ile-Lys-Ser-Arg-Ser~lu-Leu-Met-Phe~lu-Lys 
368  385 
FIGURE  1  Comparison of the synthetic peptide sequence, gamma- 
subunit sequence 360-377, and delta-subunit sequence 368-385. 
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FIGURE 2  Solid-phase ELISA screening of mab binding to peptide 
conjugate.  Binding of mabs 274D (A, A), 264E (OO), and 139A (1, 
F1) was measured as described in Materials and Methods. (A) Micro- 
titer wells were coated with BSA-peptide  conjugate  (closed sym- 
bols) or control BSA (open symbols). (B) Wells  were coated with 
KLH-peptide conjugate  (closed  symbols)  or  control  KLH  (open 
symbols). 
with a BSA conjugate of a synthetic peptide corresponding to 
residues 485-499  of the delta subunit (data not shown). 
Gamma-peptide 360-377  effectively inhibited the binding 
of mabs 264E and 274D to AChR. In an ELISA in which 
mabs were preincubated with various concentrations of pep- 
tide  before  being  added  to  wells  coated  with  AChR,  the 
peptide in its disulfide-linked  dimeric form inhibited the rate 
of binding of mab 264E and mab 274D half-maximally at 6 
uM and 30 nM, respectively  (Fig. 3).  Reduced, monomeric 
gamma peptide 360-377 also inhibited binding of mabs 264E 
and 274D but concentrations approximately threefold higher 
were necessary  to achieve half-maximal inhibition (data not 
shown).  Delta-peptide 485-499,  tested  at concentrations ex- 
ceeding 36 ~M, failed to inhibit the binding of either mab. 
The apparent affinity of  both mabs for gamma-peptide 360- 
377  was  increased  by conjugation of the  peptide  to  BSA. 
Peptide-BSA conjugate competed half-maximally with AChR 
for mabs 264E and 274D at peptide concentrations of 600 
and 2 nM, respectively (Fig. 4). BSA treated with cross-linker 
in the absence of peptide failed to inhibit the binding of 264E z 
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Fff3URE  3  Inhibition of binding of mabs to AChE by peptides. (A) 
Mabs 264E (O),  ]39A (11), 888 (e), 147A (O), 240A (x), or 280B (I-]) 
were incubated for 1 h with dimeric gamma peptide 360-377. Mab 
264E  was  also  incubated  with  delta-peptide  485-499  (A).  The 
samples were then transferred to microtiter wells coated with AChE 
and  mab  binding  was  measured  after  15  rain  as  described  in 
Materials and Methods. (B) Mab 274D was incubated with gamma- 
peptide 360-377 (&) or delta peptide 485-499 (A) for 1 h and then 
transferred to wells coated with ACHE. Mab binding was measured 
after 30 min. 
or  274D.  Neither  free  peptide  nor peptide-BSA  conjugate 
inhibited the binding to receptor of the other seven mabs. 
Mabs 264E and 274D  also immunoprecipitated  ~25I-pep- 
tide-BSA conjugate but not BSA that had been treated with 
cross-linker in the absence of peptide and then iodinated (Fig. 
5). The seven other anti-AChR mabs and mabs MPC- 11 and 
MOPC-21  failed to immunoprecipitate iodinated conjugate. 
Since  radioiodination  was  performed after conjugation  of 
peptide to BSA, most of the iodine-125 was probably incor- 
porated into tyrosine residues of BSA. Attempts to immuno- 
precipitate '25I-peptide  were less successful,  possibly because 
iodination alters the epitope(s) recognized by mabs 264E and 
274D (data not shown). 
Ultrastructural  Localization of mab Binding Sites 
Binding sites for mabs 264E and 274D were localized with 
respect to  the  lipid  bilayer in  extracted  and  nonextracted 
postsynaptic membranes from electric tissue. The former were 
receptor-rich  membrane  fragments  from  which  peripheral 
membrane proteins, which could possibly block access of the 
antibodies  to  the  receptor,  had  been  removed by alkaline 
extraction (23). They were also sonicated to ensure that the 
majority was open  or unsealed.  Gel electrophoresis in  the 
presence of SDS confirmed that substantial amounts of pro- 
tein,  including  virtually all of the  receptor-specific 43,000- 
mol-wt protein (23,  28,  35)  had been removed. The nonex- 
tracted membranes were open fragments that retain substan- 
tial amounts of postsynaptic-specific submembrane material 
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FIGURE  4  Inhibition of binding of mabs to AChE by peptide-BSA 
conjugate. (A) Mabs 264E (Q),  139A (IlL 88B (0),  147A (O),  240A 
(x), 245A (~'),  262C (~7), or 280B (I-I) were incubated for  I  h with 
peptide-BSA conjugate. Mab 264E was also incubated with control 
BSA (A).  The samples were transferred to microtiter wells coated 
with  AChE  and  mab  binding was  measured after  15  rain as  de- 
scribed in Materials and Methods. (B) Mab 274D was incubated for 
I  h  with  peptide-BSA conjugate (A)  or  control  BSA  (A)  and  the 
samples were transferred to wells coated with ACHE. Mab binding 
was measured after 30 rain. 
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FIGURE  5  Immunoprecipitation  of  1251-peptide-BSA  conjugate. 
Mabs 264E (0), 274D  (A),  139A (11), 88B  (0),  147A (~), 240A (×), 
245A (V), 262C (V), or 280B (I-]) and 274D (A) were also incubated 
for the same time period with iodinated control BSA. Immunopre- 
cipitation was measured as described in Materials and Methods. 
(R. Sealock, unpublished results),  including the 43,000-mol- 
wt protein (34). All samples were lightly fixed before labeling 
to prevent loss of material and spontaneous resealing.  Ap- 
proximately 90%  of the postsynaptic membranes remained 
open during the labeling procedures. 
Mabs 264E and 274D gave similar qualitative patterns of 
labeling on both extracted membranes (Fig. 6 A-D; small gold 
particles) and  nonextracted membranes (Fig.  6,  E  and F). 
Approximately 99% of the small gold particles (1,721  out of 
1,736 counted) in  labeled regions were on the cytoplasmic 
membrane surface, distributed essentially coextensively with 
the extracellular label on receptor-bound a-toxin (Fig.  6, A 
and B; large gold particles).  On the basis of these results,  we 
conclude  that  mabs  264E  and  274D  bind  specifically  to 
cytoplasmic determinants on the acetylcholine receptor. 
Several  findings provide additional evidence for the speci- 
ficity of mab binding.  Neither nonspecific mouse IgG (0.1 
~M; Fig. 61) nor any of four anti-43,000-mol-wt mabs (34) 
(not shown) bound  to a  significant degree to the extracted 
membranes.  Incubation  of the  mabs  with  gamma-peptide 
360-377  before their use reduced labeling due to mab 264E 
by 57% (100-~M peptide) and that due to mab 274D by 82% 
( 1-~M peptide) (Table I). These extents of inhibition are lower 
than  might be expected from the inhibition  achieved with 
ELISA (Fig. 3). However, the concentrations of the mabs were 
fivefold higher and the incubations times were longer in the 
immunocytochemical experiments. Both of these conditions 
favor increased reaction with the receptor since the mabs have 
higher affinities for the receptor than for the peptide. Finally, 
the  extracellular  label  was  specific  for  the  receptor  since 
omission of the toxin completely abolished labeling by anti- 
toxin IgG (Fig. 6 G), and addition of 10 mM carbamylcholine 
(a competitive inhibitor of toxin binding to the receptor) to 
solutions of the toxin substantially reduced the labeling (Fig. 
6 H). The explanation for the failure of carbamylcholine to 
completely abolish toxin binding appears to be analogous to 
that for peptide inhibition of binding of mab 264E. 
In nonextracted membranes, the two mabs gave quantita- 
tively similar results (Table I). In extracted membranes, how- 
ever, some quantitative differences were noted. Most receptor- 
rich regions were labeled strongly by mab 264E,  the average 
region containing almost two small gold particles for every 
large particle (Table I). Mab 274D (0.2  #M) also often gave 
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strong labeling (Fig.  6 B), but generally labeled substantially 
less well than mab 264E (approximately 0.6  small particles/ 
large particle, Table 1; Fig. 6, C and D). The labeling was not 
significantly strengthened by increasing the concentration of 
mab 274D  to  1 #M,  or by  shortening  the  wash  between 
application of the antibody and the  subsequent fixation to 
only 3 min. Mab 274D also labels less well than mab 264E if 
protein A-colloidal gold is applied directly to the mabs with- 
out rabbit antimouse IgG (unpublished results).  One expla- 
nation for these results is that mab 274D may recognize only 
the gamma-subunit of the receptor in extracted membranes 
while 264E may recognize both the gamma- and delta-chains. 
DISCUSSION 
In this study, we have shown that two mabs that recognize 
the gamma- and delta-subunits of the AChR also recognize 
the gamma peptide 360-377,  while seven other mabs against 
the receptor and two control mabs do not. Moreover, of the 
two reactive antibodies, mab 274D, which reacts preferentially 
with  the  gamma  subunit,  has  the  higher  affinity  for  the 
peptide; mab 264E, which reacts more strongly with the delta- 
subunit,  has  a  substantially  lower affinity for the  peptide. 
These observations and the relatively high affinities of both 
mabs for the peptide suggest that the reaction is highly specific. 
Thus, mabs 264E and 274D can be expected to react, in whole 
or in part, with the sequence 360-377  in the gamma-subunit 
of the intact receptor, and with the homologous region in the 
delta-subunit, since no identical sequence longer than a tri- 
peptide is found outside these regions in the same or other 
subunits. Our results thus establish that amino acid residues 
360-377  of the  receptor gamma-subunit (and  probably the 
homologous region of the  delta  chain)  reside on the  cyto- 
plasmic side of the membrane. 
Since the N-termini of the receptor subunits reside on the 
extracellular side of the postsynaptic membrane (1, 41), our 
results  require  an  uneven  number of membrane crossings 
between the N-terminus and the epitopes recognized by mabs 
264E and 274D.  They thus support models for the gamma- 
and delta-subunits in  which three hydrophobic, transmem- 
brane helices separate these two regions (5, 7, 9, 17, 26). These 
models place the region gamma 360-377  in the largest of the 
proposed cytoplasmic domains,  which  begins  near residue 
314  and ends when the polypeptide chain reenters the lipid 
bilayer, either in the region oftyr-403 (in the five helix models 
of Finer-Moore and Stroud [9] and of Guy [17]) or near val 
467  (if only four transmembrane helices  exist).  The corre- 
sponding regions of the alpha- and beta-subunits are probably 
also cytoplasmic since the conserved primary structure of all 
four subunits  suggests  a  common transmembrane arrange- 
ment (9, 26). The strong reactivity of the antibodies with this 
region further suggests that it is readily accessible.  Hence, it 
presumably lies near the surface of the domain; it is unlikely 
to be sandwiched between the  rest of the  domain  and the 
phosphate head groups of the membrane, for example. 
One  model  proposes  that  amino  acids  360-377  of the 
gamma-subunit lie within the bilayer, forming one wall of the 
receptor's ion channel (19). Our results appear to be incom- 
patible with this hypothesis. 
The antigen  used  for the production  of mabs 264E  and 
274D was affinity-purified AChR denatured with SDS before 
injection. We have shown previously that polyclonal antibod- 
ies elicited by injection of denatured AChR into rabbits were FIGURE  6  Localization of mab binding sites on postsynaptic membranes. Large gold particles: c~-toxin and antitoxin IgG. Small 
gold particles: antireceptor mabs. (A-D and G-I)  Extracted membranes. (E and /3  Nonextracted membranes. (A)  Labeled with 
mab 264E.  Some receptor-rich regions are not labeled by  the  a-toxin due to steric block by  adjacent membrane fragments 
(arrows). Contaminating nonpostsynaptic membranes are not labeled (arrowheads). (B-D) Labeled with mab 274D. The antibody 
sometimes labeled strongly (/3), but it generally labeled more weakly (C and D) than mab 264E. (E) Labeled with mab 264E. This 
nonextracted membrane retained associated cytoplasmic filaments (~). (F) Labeled with mab 274D.  (G) Labeled with antitoxin, 
but without a-toxin or mabs. The  membranes shown are probably postsynaptic membranes, as judged by their morphology. 
They are typical of the sample. (H)  Exposed to a-toxin in the presence of 10 mM carbamylcholine, then labeled with antitoxin 
IgG. Labeling was decreased but not abolished. (I) Labeled with mouse control IgG in place of mabs. Background labeling on the 
cytoplasmic surface of the membrane shown (four small gold particles) is higher than on most membranes in the sample. Bar, 
100 nm (A-D and F-H) or 115 nm (/? and I). (A-D and F-/-/; x  76,000).  (E and I; x  66,000). 
directed  primarily  against  cytoplasmic  determinants  (11). 
Similar results were obtained in the production of monoclonal 
antibodies  (13,  32). Mabs  88B  and  147A (both  of which 
recognize the gamma- and delta-subunits) compete with each 
other and with mab 264E in binding to native AChR (S. C. 
Froehner, unpublished results), suggesting that they recognize 
epitopes that lie close to each other. Thus, four out of fourteen 
mabs raised against AChR appear to be directed against a 
relatively small, highly antigenic sequence that possesses con- 
siderable homology between the gamma- and  delta-chains. 
Predictions of the secondary structure of the region encore- 
passing residues  360-377  of the gamma-chain suggest that it 
lacks both alpha-helix and beta-sheet structure (9). It is intri- 
guing that an extracellular region of the alpha-chain (residues 
161-166) that has been proposed (26) as a candidate for the 
"main immunogenic region" (37)  is also predicted to lack 
these common ordered structures. 
Mabs 264E, 88B, and 147A have previously been shown to 
react with the receptor in frog muscle in immunofluorescence 
experiments, but  only  if the  antibodies  had  access  to  the 
muscle cytoplasm (13).  Mabs 88B and  147A also react with 
rat muscle (13).  These results predict that muscle receptors 
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Binding of Antireceptor mabs to Postsynaptic Membranes 
Ratio (+ peptide)] 
Ratio  Ratio (- peptide) 
Extracted membranes 
264E  1.69 
264E +  peptide (100 p.M)  0.72 
274D  0.56 
274D +  peptide (I #M)  0.10 
Nonextracted membranes 
264E  0.81 
274D  1.09 
0.43 
0.18 
The signal  for bound antireceptor mabs is expressed relative to that for bound 
o~-toxin:  ratio =  number of small  gold  particles  on the  cytoplasmic  surface/ 
number of large gold particles on the extracellular  surface. 
from a variety of species have a region corresponding to and 
having considerable homology with gamma 360-377 and the 
surrounding regions of the  Torpedo receptor.  Recent deter- 
mination of  the primary structure of the gamma-subunit from 
calf muscle has confirmed this prediction (44). 
A major function of the cytoplasmic domains of the recep- 
tor  subunits  may be  to  interact  with  postsynaptic-specific, 
submembrane proteins. One such protein, the 43,000-mol-wt 
protein  (28),  has been  shown by immunogold electron  mi- 
croscopy (34),  and  ultrastructural  morphology  (33)  to  be 
coextensively distributed with the receptor and to lie among 
or adjacent to the cytoplasmic regions of the receptor.  The 
43,000-mol-wt protein has also been chemically cross-linked 
to  the  beta  subunit  of the  membrane-bound  receptor  (3). 
Thus, it may interact directly with cytoplasmic domains of 
the receptor, possibly serving to anchor the receptor at post- 
synaptic sites (4, 20, 30). The fact that mabs 264E and 274D 
react  well  with  the  receptor  in  nonextracted  membranes 
(which retain  the 43,000-mol-wt protein  [34]) and  in  fixed 
electroplax (unpublished results) appears to rule out the pos- 
sibility that association of the 43,000-mol-wt protein with the 
receptor  could  involve  the  region  of gamma  360-377.  In 
addition,  mab  88B  also  reacts  well  with  the  postsynaptic 
membrane in fixed electroplax (unpublished results).  Hence, 
there  may  be  a  substantial  portion  of the  receptor  in  the 
region of gamma 360-377 that is not close to the 43,000-mol- 
wt protein. This conclusion probably cannot be extended to 
the homologous region of the delta-subunit  on the basis of 
the present data,  since mab 264E reacted less  well  with the 
nonextracted membranes than with the extracted membranes. 
In previous experiments, several anti-AChR mabs, includ- 
ing 264E and 274D, reacted with the membrane-bound AChR 
only after alkaline extraction of purified receptor-rich mem- 
brane  vesicles  (13)  and  we  suggested  that  the  removal  of 
peripheral  membrane  proteins  uncovered the  mab-binding 
sites. Although this point needs to be investigated for the other 
mabs that showed these binding characteristics, the results in 
this  paper make it  more likely that the important effect of 
alkaline extraction was to open the vesicles. 
The polypeptide segment containing the cytoplasmic epi- 
topes that we have identified has recently been proposed to 
contain sites of phosphorylation (40).  According to this pro- 
posal, tyrosine-364 of the gamma subunit can be phosphoryl- 
ated  by  a  tyrosine  kinase  endogenous  to  the  postsynaptic 
membrane preparation.  In addition, phosphorylation on the 
gamma and delta subunits by a cAMP-dependent kinase and 
on the delta-subunit by protein kinase C may occur on serine 
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residues close to but not contained within  gamma 360-377 
(40). Mabs 264E and 274D as well as others thought to bind 
to adjacent  regions  may be  useful  tools for verifying these 
sites of phosphorylation and for investigations of the effects 
of these modifications on receptor function. 
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Note Added in Proof.  Antibodies to synthetic peptides based on the 
region of the beta subunit  that corresponds in position to gamma 
340-349 and on the C-terminal region of  the delta chain have recently 
been reported to bind to the cytoplasmic surface of the electrocyte 
postsynaptic membrane  (E. F. Young, E. Ralston, J.  Blake, J. Ra- 
machandran,  Z. W. Hall, and R. M. Stroud,  1985, Proc. Natl. Acad 
Sci. USA. 82:In press). 
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